result larg in-lin expect emphasi remain
liquid capit preserv on-going product invest
emerg stronger maintain buy pt
maintain buy rate pt follow
result revenu in-lin pre-announc declin
y/i y/i xfx better-than-expect result estim within
dental spine cmft knee hip weaker although
surpris variat geograph exposur sell day activ
hip declin largest among big snn
knee declin
snn similar peer expect trough april overal exit rate
rel plan variat geographi busi line management
expect sequenti revenu growth although commentari suggest
gradual recoveri somewhat less sanguin view revenu tie
elect procedur share recov low late
march valuat in-lin histor average recoveri share
alreadi bake view economi procedur activ return
come quarter see less opportun multipl expans given share
trade today growth improv margin improv ensu drive out-year
ep estim higher like allow share grind higher
liquid financi flexibl management refinanc debt came due
april renegoti term revolv secur addit
credit facil exit cash cash equival management
initi cost save initi includ broad-bas salari reduct
otherwis continu execut restructur program announc
aim invest achiev annual cost
save drive om non-linear time cadenc om
end y/i lower revenu management expect
revenu improv margin expand
april challeng m/m improv revenu
y/i last two week y/i april elect procedur
revenu defer apac revenu q/q china
revenu declin mid-mar thereaft increas exit
apr weekli improv japan zbh largest apac
market see materi impact covid apr revenu
remain stabl level emea revenu
q/q itali spain franc uk other exit procedur
y/i germani austria switzerland other exit
y/i emea procedur remain y/i april lastli america
decreas q/q last two week revenu declin y/i
april us revenu remain y/i
y/i management expect littl chang headwind seen
across industri
valuat rate buy pt base mo
estim ep risk discuss
factset btig estim compani
document million except per share amount
made signific improv turnaround busi risk tabl believ
major manufactur cultur challeng exist prior diminish creat unpreced
challeng compani expos due slowdown elect procedur said recoveri
like beyond see revenu growth margin growth pick back allow share grind higher
launch rosa spine
anticip impact sale forc special
on-going roll-out persona revis
potenti realiz initi sg improv
base case scenario call weather pandem
return portion sale guidanc suspend difficult know
exactli amount model declin revenu gradual
improv year
upsid estim could come faster recoveri pandem
adopt npi reinvigor sale forc stronger product addit
upsid could seen greater rosa placement rapid adopt new
indic upsid could seen rapid realiz oper
leverag restructur initi
downsid like come wors expect uptak npi
nag coronaviru worsen moral competit loss sale forc
worsen margin push competit account
downsid could seen disappoint rosa launch delay npi longer
expect costli restructur program
zimmer biomet diversifi medic
technolog compani design
manufactur broad rang
zimmer hold found
justin zimmer took
current form zimmer acquir
biomet inc april today zimmer
biomet oper global countri
employe across
zimmer biomet report result overal revenu came y/i y/i xfx
consensu pre-covid expect y/i y/i respect segment report
revenu y/i knee y/i hip y/i y/i
dental spine cmft y/i compar our/consensu pre-covid prior chang
revenu report estim y/i knee y/i hip
y/i y/i dental
y/i spine cmf y/i respect constant currenc revenu growth
y/i pre-covid expect y/i
adj gross margin pre-covid estim percentag revenu sg came
versu pre-covid expect respect adj ep quarter
consensu pre-covid estim respect
btig research estim compani file
made follow chang model
within revenu lower estim account larger declin gradual recoveri
balanc year expect declin base lower revenu base difficult know exactli
signific may given earli natur pandem declin base management commentari geographi
overal result like averag april slight improv may june
 lower gm expect declin lower revenu given
cost fix expect lower cost absolut dollar basi opex revenu like significantli
higher tweak oi line continu pay back debt
btig research estim compani file
sale
cog revenu
sg revenu
 revenu
btig research estim compani report
btig research estim compani report
btig cover compani mention report
appendix analyst certif import disclosur
